420 related articles for article (PubMed ID: 24803295)
1. Dexmedetomidine controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Xiang H; Hu B; Li Z; Li J
Inflammation; 2014 Oct; 37(5):1763-70. PubMed ID: 24803295
[TBL] [Abstract][Full Text] [Related]
2. [Role of α7 nicotinic acetylcholine receptor in attenuation of endotoxin induced delirium with dexmedetomidine in mice].
Zhang X; Li Z; Sun X; Jin F; Liu J; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Feb; 28(2):127-33. PubMed ID: 26911944
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine attenuates inflammatory reaction in the lung tissues of septic mice by activating cholinergic anti-inflammatory pathway.
Liu Z; Wang Y; Wang Y; Ning Q; Zhang Y; Gong C; Zhao W; Jing G; Wang Q
Int Immunopharmacol; 2016 Jun; 35():210-216. PubMed ID: 27074053
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine-Mediated Prevention of Renal Ischemia-Reperfusion Injury Depends in Part on Cholinergic Anti-Inflammatory Mechanisms.
Ma J; Chen Q; Li J; Zhao H; Mi E; Chen Y; Yi B; Ning J; Ma D; Lu K; Gu J
Anesth Analg; 2020 Apr; 130(4):1054-1062. PubMed ID: 30346356
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine attenuates lipopolysaccharide-induced inflammation through macrophageal IL-10 expression following α7 nAchR activation.
Han QQ; Li XY; Wang YX
Int Immunopharmacol; 2022 Aug; 109():108920. PubMed ID: 35691275
[TBL] [Abstract][Full Text] [Related]
7. The role of the vagus nerve on dexmedetomidine promoting survival and lung protection in a sepsis model in rats.
Li Y; Wu B; Hu C; Hu J; Lian Q; Li J; Ma D
Eur J Pharmacol; 2022 Jan; 914():174668. PubMed ID: 34863997
[TBL] [Abstract][Full Text] [Related]
8. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling.
Parrish WR; Rosas-Ballina M; Gallowitsch-Puerta M; Ochani M; Ochani K; Yang LH; Hudson L; Lin X; Patel N; Johnson SM; Chavan S; Goldstein RS; Czura CJ; Miller EJ; Al-Abed Y; Tracey KJ; Pavlov VA
Mol Med; 2008; 14(9-10):567-74. PubMed ID: 18584048
[TBL] [Abstract][Full Text] [Related]
9. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
Yu T; Liu D; Gao M; Yang P; Zhang M; Song F; Zhang X; Liu Y
Biomed Pharmacother; 2019 Dec; 120():109231. PubMed ID: 31546082
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine attenuates inflammation and pancreatic injury in a rat model of experimental severe acute pancreatitis via cholinergic anti-inflammatory pathway.
Huang DY; Li Q; Shi CY; Hou CQ; Miao Y; Shen HB
Chin Med J (Engl); 2020 May; 133(9):1073-1079. PubMed ID: 32265428
[TBL] [Abstract][Full Text] [Related]
11. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.
Pavlov VA; Parrish WR; Rosas-Ballina M; Ochani M; Puerta M; Ochani K; Chavan S; Al-Abed Y; Tracey KJ
Brain Behav Immun; 2009 Jan; 23(1):41-5. PubMed ID: 18639629
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway.
Kang K; Gao Y; Wang SC; Liu HT; Kong WL; Zhang X; Huang R; Qi ZD; Zheng JB; Qu JD; Liu RJ; Liu YS; Wang HL; Yu KJ
Biomed Pharmacother; 2018 Oct; 106():210-216. PubMed ID: 29960167
[TBL] [Abstract][Full Text] [Related]
13. Effect of dexmedetomidine and cholinergic anti-inflammatory pathways in myocardial ischemia-reperfusion injury.
Ju Y; Xiao F; Lu J; Zhou B; Cai J; Chen S
Pak J Pharm Sci; 2020 May; 33(3(Special)):1377-1382. PubMed ID: 33361026
[TBL] [Abstract][Full Text] [Related]
14. Protective role of the cholinergic anti-inflammatory pathway in a mouse model of viral myocarditis.
Cheng Z; Li-Sha G; Jing-Lin Z; Wen-Wu Z; Xue-Si C; Xing-Xing C; Yue-Chun L
PLoS One; 2014; 9(11):e112719. PubMed ID: 25396421
[TBL] [Abstract][Full Text] [Related]
15. 3-Dehydroandrographolide protects against lipopolysaccharide-induced inflammation through the cholinergic anti-inflammatory pathway.
Lu Z; Xie P; Zhang D; Sun P; Yang H; Ye J; Cao H; Huo C; Zhou H; Chen Y; Ye W; Yu L; Liu J
Biochem Pharmacol; 2018 Dec; 158():305-317. PubMed ID: 30391477
[TBL] [Abstract][Full Text] [Related]
16. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury.
Zhang J; Xia F; Zhao H; Peng K; Liu H; Meng X; Chen C; Ji F
PLoS One; 2019; 14(7):e0218726. PubMed ID: 31344138
[TBL] [Abstract][Full Text] [Related]
17. Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia.
Bell MT; Agoston VA; Freeman KA; Puskas F; Herson PS; Mares J; Fullerton DA; Reece TB
J Vasc Surg; 2014 Apr; 59(4):1090-7. PubMed ID: 23850057
[TBL] [Abstract][Full Text] [Related]
18. Effects of dexmedetomidine on lipopolysaccharide-induced acute kidney injury in rats and mitochondrial function in cell culture.
Kiyonaga N; Moriyama T; Kanmura Y
Biomed Pharmacother; 2020 May; 125():109912. PubMed ID: 32014689
[TBL] [Abstract][Full Text] [Related]
19. Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of K
Minaei A; Haghdoost-Yazdi H
Toxicol Appl Pharmacol; 2019 Nov; 382():114743. PubMed ID: 31476326
[TBL] [Abstract][Full Text] [Related]
20. Activation of cholinergic anti-inflammatory pathway involved in therapeutic actions of α-mangostin on lipopolysaccharide-induced acute lung injury in rats.
Yang Z; Yin Q; Olatunji OJ; Li Y; Pan S; Wang DD; Zuo J
Int J Immunopathol Pharmacol; 2020; 34():2058738420954941. PubMed ID: 32886564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
